Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.429.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.429.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.429.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
P.1.9 (Gamma)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
P.1.9 (Gamma)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
P.1.9 (Gamma)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
P.1.9 (Gamma)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-6672.85US
AY.25.1.1 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.25.1.1 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.25.1.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.25.1.1 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.203ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.203ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.203ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.203NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.157ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.157ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.157ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.157NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.176ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.176ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.176ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.176NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.3.4 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.3.4 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.3.4 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.3.4 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.391ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.391ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
B.1.1.391ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
B.1.1.391NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.393ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.393ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.393ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.393NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.432ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.432ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.432ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.432NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.388ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.388ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.388ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.388NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
P.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
P.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
P.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
P.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.48ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.48ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.48ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used